Indeus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 16-12-2024
- Paid Up Capital ₹ 20.22 Cr
as on 16-12-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -47.31%
(FY 2022)
- Profit -1398.93%
(FY 2022)
- Ebitda -1133.37%
(FY 2022)
- Net Worth -31.45%
(FY 2022)
- Total Assets -11.77%
(FY 2022)
About Indeus Life Sciences
The Corporate was formerly known as Indec Life Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 20.22 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Indeus Life Sciences Private Limited India is Kanchan Kulkarni as COMPANY SECRETARY. Dharmaraj Shetty, Samir Gaikwad, Shantisudha Shetty, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232MH2007PTC168501
- Company No.
168501
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Indeus Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmaraj Shetty  | Managing Director | 30-Mar-2020 | Current |
| Kanchan Kulkarni | Company Secretary | 03-Jan-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Samir Gaikwad | Nominee Director | 07-Apr-2023 | Current |
| Shantisudha Shetty | Director | 22-Feb-2021 | Current |
Finny Joseph  | Director | 24-Sep-2021 | Current |
Financial Performance of Indeus Life Sciences.
Indeus Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 47.31% decrease. The company also saw a substantial fall in profitability, with a 1398.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indeus Life Sciences?
In 2023, Indeus Life Sciences had a promoter holding of 44.87% and a public holding of 55.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Genocare Pharma Private LimitedActive 5 years 2 monthsDharmaraj Shetty and Shantisudha Shetty are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indeus Life Sciences?
Indeus Life Sciences has a workforce of 36 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indeus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indeus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
